- Medical School - University of Kentucky College of Medicine (2010-2014)
- Fellowship - UT Southwestern Medical Center (2018-2020), Autoimmune Neurology
- Residency - University of Texas Southwestern Medical School (2014-2018), Neurology
Kyle Blackburn, M.D.
NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP).
Blackburn KM, Ivleva EI, Weir RA, Kim M, Hopkins SC, Hudgens-Haney ME, Keedy SK, Gershon ES, Sweeney JA, Keshavan MS, Pearlson GD, Clementz BA, Tamminga CA, Vernino S, Schizophrenia research 2020 Jan
Neurological autoimmune disorders with prominent gastrointestinal manifestations: A review of presentation, evaluation, and treatment.
Blackburn KM, Kubiliun M, Harris S, Vernino S, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2019 Apr e13611
Diagnostic and therapeutic strategies for management of autoimmune encephalopathies.
Dubey D, Blackburn K, Greenberg B, Stuve O, Vernino S Expert review of neurotherapeutics 2016 May 1-13
Two cases of aquaporin-4 positive neuromyelitis optica associated with T-cell lymphoma.
Blackburn K, Wang C, Greenberg B, Journal of neuroimmunology 2019 Oct 338 577092
Assessing recent suicidal ideation and behavior in the adult epilepsy monitoring unit.
Husari KS, Blackburn KM, Ding K, Roaten K, Hays R, Epilepsy & behavior : E&B 2019 Mar 94 100-103
- NMDA receptor antibody seropositivity in psychosis: A pilot study from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP).